NCT06178926View on ClinicalTrials.gov

Ciprofol Sedation in Patients Undergoing Liver Cancer Percutaneous Radiofrequency Ablation

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
Liver CancerCiprofol
Interventions
DRUG

Propofol

Propofol was IV infused 1.0-1.5mg/Kg and then maintenance at 1.0-2.0mg/Kg/h

DRUG

Ciprofol

Ciprofol was IV infused 0.2- 0.3mg/Kg and then maintenance at 0.2-0.3mg/Kg/h

Trial Locations (1)

310022

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

All Listed Sponsors
lead

Zhejiang Cancer Hospital

OTHER